India information India

Covid propels India pharma sales in May; Glenmark, Cipla, Alkem outperform

Reading now: 432
www.livemint.com

drugs continued. Sales of anti-infectives, respiratory, and vitamins and minerals grew 142%, 87% and 60% year-on-year respectively, suggest analysts reports.India Ratings and Research said the growth in India’s pharmaceutical market during May was led by a low base effect.

IPM growth had declined 8.5% year-on-year in May 2020.However, adjusting for low base and covid drug sales, analysts at Jefferies India believe growth was at 20% year-on-year.

Absolute sales value remained at the levels of April. Like the previous month, growth in May was led by acute segment, which was up 70% year-on-year.

Sub-chronic segment grew 38%, while the chronic segment rose 28%, added analysts at Jefferies.During May, volumes grew 31.5% year-on-year.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA